注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Gelesis Holdings Inc是一家商业阶段的生物治疗公司,旨在促进消费者参与。该公司专注于推进用于慢性胃肠道(GI)疾病的超吸收性水凝胶疗法,包括超重、二型糖尿病、非酒精性脂肪肝病(NAFLD)/非酒精性脂肪性肝炎(NASH)、功能性便秘(FC)和炎症性肠病。其产品Plenity是一种口服胶囊。Plenity可以通过远程医疗咨询获得处方,与接受过体重管理支持培训的医生进行远程医疗咨询,并根据需要免费、无限制地进行随访。消费者可登陆myplenity.com进行在线咨询。该公司的其他管道候选产品包括用于糖尿病前期和二型糖尿病减肥的GS200。其还正在开发用于治疗NAFLD和NASH的GS300,以及用于治疗FC的GS500。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Louis J. Aronne | 66 | 2015 | Member of Scientific Advisory Board |
James Hill | - | - | Member of Scientific Advisory Board |
Allan Geliebter | - | - | Member of Scientific Advisory Board |
Hassan M. Heshmati | 70 | 2020 | Member of Scientific Advisory Board |
Angelo Tremblay | - | 2015 | Member of Scientific Advisory Board |
Caroline M. Apovian | - | - | Member of Scientific Advisory Board |
Alison Perry Bauerlein | 41 | 2022 | Independent Director |
Lee M. Kaplan | - | - | Member of Scientific Advisory Board |
Arne V. Astrup | - | - | Member of Scientific Advisory Board |
Ken Fujioka | - | 2015 | Member of Scientific Advisory Board |
Bennett M. Shapiro | 82 | - | Member of Scientific Advisory Board |
Clayton Christopher | 48 | - | Independent Director |
Jane Larsen Wildman | 60 | 2021 | Independent Director |
Paul R. Fonteyne | 62 | 2022 | Independent Director |
Kathryn E. Cavanaugh | 48 | 2022 | Independent Director |
Yishai Zohar | 60 | 2022 | Founder, President, CEO, Chief Compl. Officer, Secretary, Treasurer, Interim PFO and PAO & Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核